Filterrapport
UltraHome — svensk översättning av labbrapporten
Detta är en översättning från engelska av AlkaVivas dokument UltraHome Whole House Water Filtration System Testing Protocol. Certifikat, laboratorium, protokoll och siffror är desamma som i originalet. Vi har inte lagt till egna mätningar.
Livsvatten säljer systemet i Sverige. Originalet är tillverkarens sammanfattning av labbets resultat — inte ett svenskt hälsopåstående. Kolumnen om sjukdomar i PDF:en är EPA-exempeltext; den är inte översatt hit. Siffrorna är.
Öppna originalet (PDF, engelska) Tillbaka till UltraHome Jonisatorfiltrets rapport (249 ämnen)
Som överst i originalet
Laboratorium, certifikat och protokoll
AlkaViva LLC
8745 Technology Way, Suite C
Reno, NV 89521, USA
Telefon (775) 324-2400 · customerservice@alkaviva.com
AlkaViva UltraHome helhusfilter — testprotokoll
Systemtest utfört 8 juni 2022 av QFT Labs. QFT Labs förvärvades därefter av IAPMO.
- IAPMO är ackrediterat av både ANSI och SCC och agerar som oberoende bedömnings- och certifieringsorgan.
- IAPMO utför material- och produktlistning och märkning och är en accepterad global auktoritet.
- Provvattnet följde NSF/ANSI:s allmänna testvatten. Ämnen spikades enligt NSF/ANSI 53, NSF/ANSI 42 och EPA:s direkta protokoll, om inte annat anges i testdokumenten.
- In- och utvärden mättes med matchad EPA-metod för varje ämne.
- QFT Laboratory testade produkten och lämnade alla resultat 2022-06-08. Originala labbrapporter finns att begära hos tillverkaren.
Hur testet gjordes
Allt i dokumentet kördes i ett nedskalat kärl (4,5 × 20 tum inline-hus, volym 318,09 in³) med flöde 0,5 gal/min. Storlek och flöde sattes för att motsvara helhussystemets volym vid ett antaget hushållsflöde på 6,0 gal/min. Flödet påverkar resultatet.
500 gallon kommunalt testvatten kördes genom varje enhet för att konditionera den. Därefter spikades ämnena, analyserades på inflödet, och 35 liter av den lösningen kördes genom systemet. Utflödet mättes. En testenhet per protokoll — samma enhet användes inte till flera protokoll, så att joner inte skulle störa varandra.
Fluorid i slutet av rapporten: flöde 1,0 gpm, cykel 20 min på / 20 min av, total volym 300. Reduktion 0,0 % — UltraHome tar inte bort fluorid i det testet.
Ordlista (som i originalet)
- Influent — lösningen före filtret. Används för att räkna reduktion. Halterna är satta efter standardprotokoll.
- Effluent — lösningen efter filtret.
- mg/L — milligram per liter, samma som ppm.
- µg/L — mikrogram per liter, samma som ppb.
- ND — under detekterbar nivå för utrustningen i EPA-protokollet.
Användarvänlig sammanfattning
Här är labbets siffertabell, översatt i rubrikerna. Ämnesnamnen lämnas som i originalet så att du kan jämföra rad för rad mot PDF:en. Rapporten räknar 229 ämnen.
| Ämne (namn som i originalet) | Reduktion | In (influent) | Enhet | Ut (effluent) |
|---|---|---|---|---|
| Perfluorobutane Sulfonate | 98.0% | 1.01 | µg/L | 0.02 |
| hypertension and preeclampsia | 96.2% | 0.52 | µg/L | 0.02 |
| fetus, and | 96.2% | 0.52 | µg/L | 0.02 |
| breastfed infants | 96.2% | 0.52 | µg/L | 0.02 |
| cholesterol, and | 96.2% | 0.52 | µg/L | 0.02 |
| Iron | 99.49% | 2726 | µg/L | 14 |
| Nickel | 99.34% | 302 | µg/L | 2 |
| Chromium (Total) | 99.01% | 302 | µg/L | 3 |
| Aluminum | 98.1% | 210 | µg/L | 4 |
| Cadmium | 96.68% | 30.1 | µg/L | <1 |
| Manganese | 94.55% | 918 | µg/L | 50 |
| Barium | 93.56% | 202 | µg/L | 13 |
| Lead | 92.57% | 148 | µg/L | 11 |
| Beryllium | >91.8% | 6.1 | µg/L | <0.5 |
| Mercury | >91.8% | 6.1 | µg/L | <0.5 |
| Copper | 86.08% | 3009 | µg/L | 419 |
| Arsenic | 56.57% | 49.5 | µg/L | 21.5 |
| 2,4,5-T | >99.9% | 150.2 | µg/L | <0.1 |
| Acifluoren | 99.8% | 41.7 | µg/L | 0.1 |
| 2,4-DB | 99.7% | 32.7 | µg/L | 0.1 |
| Bentazon | 99.7% | 39.5 | µg/L | 0.1 |
| Pentachlorophenol | 99.6% | 22.5 | µg/L | 0.1 |
| 2,4-D | 99.5% | 22.1 | µg/L | 0.1 |
| 2,4,5-TP | 99.5% | 18.6 | µg/L | 0.1 |
| Dinosep | >99.8% | 52.1 | µg/L | <0.1 |
| Picloram | >99.8% | 40.0 | µg/L | <0.1 |
| DCPA | >99.8% | 42.5 | µg/L | <0.1 |
| Quinclorac | >99.8% | 43.5 | µg/L | <0.1 |
| Chloramben | >99.6% | 28.1 | µg/L | <0.1 |
| Glyphosate | 99.9% | 804 | µg/L | 0.1 |
| anemia | >99.9% | 502 | µg/L | <0.1 |
| 2,4-D | >99.8% | 50.1 | µg/L | <0.1 |
| Aldrin | >99.8% | 50.5 | µg/L | <0.1 |
| anemia | >99.8% | 50.0 | µg/L | <0.1 |
| Atrazine | >99.8% | 100.4 | µg/L | 0.1 |
| levels of sex hormones in the | >99.8% | 50.1 | µg/L | <0.1 |
| Bromacil | >99.8% | 50.1 | µg/L | <0.1 |
| Butachlor | >99.8% | 50.2 | µg/L | <0.1 |
| Butylate | >99.8% | 41.1 | µg/L | <0.1 |
| Carbofuran | >99.8% | 80.4 | µg/L | 0.1 |
| Chlorneb | >99.8% | 50.5 | µg/L | <0.1 |
| Chlorpropane | >99.8% | 52.5 | µg/L | <0.1 |
| coordination | >99.8% | 50.2 | µg/L | <0.1 |
| Chlorthalonil | >99.8% | 51.2 | µg/L | <0.1 |
| coordination, tremors, convulsions, and death | >99.8% | 50.5 | µg/L | <0.1 |
| Cyanizine Dermatits, acute toxicity | >99.8% | 50.5 | µg/L | <0.1 |
| Delta-BHC | >99.8% | 50.1 | µg/L | <0.1 |
| convulsions, and coma | >99.8% | 51.4 | µg/L | <0.1 |
| Dieldrin | >99.8% | 48.2 | µg/L | <0.1 |
| Diphenamid | >99.8% | 49.0 | µg/L | <0.1 |
| salivation | >99.8% | 50.2 | µg/L | <0.1 |
| Endosulfan I Tremors | >99.8% | 42.0 | µg/L | <0.1 |
| Endosulfan II Tremors | >99.8% | 40.2 | µg/L | <0.1 |
| Endrin | >99.8% | 61.3 | µg/L | <0.1 |
| Endrin Aldehyde | >99.8% | 45.1 | µg/L | <0.1 |
| Endrin Ketone | >99.8% | 50.3 | µg/L | <0.1 |
| Ethoprop | >99.8% | 50.4 | µg/L | <0.1 |
| Fenamiphos | >99.8% | 52.1 | µg/L | <0.1 |
| Fenarimol None | >99.8% | 50.0 | µg/L | <0.1 |
| Fluoridone None | >99.8% | 50.1 | µg/L | <0.1 |
| Gamma-BHC (Lindane) | >99.8% | 50.2 | µg/L | <0.1 |
| Heptachlor Risk of | >99.8% | 51.4 | µg/L | <0.1 |
| Heptachlor Epoxide Risk of | >99.8% | 50.2 | µg/L | <0.1 |
| Hexachlorobenzene | >99.8% | 50.1 | µg/L | <0.1 |
| Hexachlorocyclopentadiene | >99.8% | 52.0 | µg/L | <0.1 |
| Methoxychlor | >99.8% | 50.1 | µg/L | <0.1 |
| Metolachlor | >99.8% | 50.2 | µg/L | <0.1 |
| Metribuzin | >99.8% | 50.2 | µg/L | <0.1 |
| Molinate | >99.8% | 50.1 | µg/L | <0.1 |
| DDD | >99.8% | 44.1 | µg/L | <0.1 |
| DDE | >99.8% | 56.0 | µg/L | <0.1 |
| DDT Headaches | >99.8% | 60.5 | µg/L | <0.1 |
| immune deficiencies | >99.8% | 10.4 | µg/L | <0.1 |
| Propachlor None | >99.8% | 50.2 | µg/L | <0.1 |
| Simazine | >99.8% | 50.1 | µg/L | <0.1 |
| Toxaphene | >99.8% | 15.1 | µg/L | <0.1 |
| Trans-Chlordane GI distress and neurological sym | >99.8% | 50.1 | µg/L | <0.1 |
| 1, 1, 1-Trichloroethane | >99.9% | 84.8 | µg/L | <0.1 |
| 1, 1, 2, 2-Tetrachloroethane | >99.9% | 81.2 | µg/L | <0.1 |
| 1, 1, 2-Trichloroethane | >99.9% | 110.1 | µg/L | <0.1 |
| 1, 1-Dichloroethane | >99.9% | 92.3 | µg/L | <0.1 |
| 1, 1-Dichloroethene | >99.9% | 78.1 | µg/L | <0.1 |
| 1, 2-Dichlorobenzene | >99.9% | 80.0 | µg/L | <0.1 |
| 1, 2-Dichloroethane | >99.9% | 88.5 | µg/L | <0.1 |
| 1, 2-Dichloropropane | >99.9% | 80.1 | µg/L | <0.1 |
| 1, 3-Dichloropropane | >99.9% | 92.2 | µg/L | <0.1 |
| Benzene | >99.9% | 80.0 | µg/L | <0.1 |
| Bromochloromethane | >99.9% | 80.8 | µg/L | <0.1 |
| Carbon Tetrachloride | >99.9% | 88.0 | µg/L | <0.1 |
| Chlorobenzene | >99.9% | 77.2 | µg/L | <0.1 |
| cis-1, 2-Dichloroethene | >99.9% | 181.5 | µg/L | <0.1 |
| Ethylbenzene | >99.9% | 88.2 | µg/L | <0.1 |
| m and p-Xylene Nervous system | >99.9% | 80.3 | µg/L | <0.1 |
| MTBE | >99.9% | 73.4 | µg/L | <0.1 |
| Naphthalene Hemolytic anemia | >99.9% | 160.5 | µg/L | <0.1 |
| Styrene | >99.9% | 150.0 | µg/L | <0.1 |
| Tetrachloroethene Likely carcinogen | >99.9% | 85.6 | µg/L | <0.1 |
| Toluene Nervous system | >99.9% | 78.3 | µg/L | <0.1 |
| trans-1, 2-Dichloroethene | >99.9% | 78.2 | µg/L | <0.1 |
| trans-1, 3-Dicloropropene | >99.9% | 79.9 | µg/L | <0.1 |
| 1, 3-Dichlorobenzene | >99.8% | 40.2 | µg/L | <0.1 |
| 1, 4-Dichlorobenzene | >99.8% | 40.0 | µg/L | <0.1 |
| Chloromethane | >99.8% | 50.2 | µg/L | <0.1 |
| Dibromo-3-Chloropropane | >99.8% | 50.2 | µg/L | <0.1 |
| system, or kidneys | >99.8% | 44.8 | µg/L | <0.1 |
| Hexachlorobutadiene | >99.8% | 44.2 | µg/L | <0.1 |
| o-Xylene Nervous system | >99.8% | 40.2 | µg/L | <0.1 |
| Vinychloride | >99.8% | 42.3 | µg/L | <0.1 |
| Dibromoacetonitrile | >99.6% | 24.6 | µg/L | <0.1 |
| Flourotrichloromethane Irregular heartbeat | >99.6% | 28.3 | µg/L | <0.1 |
| 1, 2, 3-Trichloropropane | >99.5% | 19.2 | µg/L | <0.1 |
| Bromoacetonitrile Build-up of fluid in lungs | >99.5% | 20.5 | µg/L | <0.1 |
| Bromomethane | >99.5% | 21.3 | µg/L | <0.1 |
| Dibromomethane | >99.5% | 18.4 | µg/L | <0.1 |
| Methylene Chloride Harms eyes, skin | >99.4% | 18.0 | µg/L | <0.1 |
| 1, 2, 3-Trichlorobenzene Changes to adrenal glan | >99.3% | 14.2 | µg/L | <0.1 |
| 1, 2, 4-Trichlorobenzene Changes to adrenal glan | >99.3% | 13.6 | µg/L | <0.1 |
| 1,1,1-Trichloro-2 | >99.3% | 14.5 | µg/L | <0.1 |
| Trichloroacetonitrile | >99.3% | 15.0 | µg/L | <0.1 |
| Bromobenzene | >99.2% | 12.5 | µg/L | <0.1 |
| 4-Chlorotoluene | >99.1% | 10.9 | µg/L | <0.1 |
| 1, 2, 4-Trimethylbenzene Causes | >99.0% | 9.90 | µg/L | <0.1 |
| 2, 2-Dichloropropane | >99.0% | 10.0 | µg/L | <0.1 |
| 2-Chlorotoluene | >99.0% | 10.0 | µg/L | <0.1 |
| 4-Isopropyltoluene | >99.0% | 10.3 | µg/L | <0.1 |
| Dichloroacetonitrile | >99.0% | 9.92 | µg/L | <0.1 |
| n-Butylbenzene | >99.0% | 10.2 | µg/L | <0.1 |
| Tert-Butylbenzene | >99.0% | 10.1 | µg/L | <0.1 |
| 1, 3, 5-Trimethylbenzene | >98.9% | 9.5 | µg/L | <0.1 |
| fainting | >98.9% | 9.37 | µg/L | <0.1 |
| 1, 1-Dichloropropane | >98.8% | 8.67 | µg/L | <0.1 |
| 1,1-Dichloro-2-propanone | >98.7% | 7.50 | µg/L | <0.1 |
| sec-Butylbenzene | >98.7% | 7.88 | µg/L | <0.1 |
| unconsciousness | >98.5% | 6.78 | µg/L | <0.1 |
| Dalapon | >99.96% | 270.2 | µg/L | <0.1 |
| Dicamba | >99.9% | 150.7 | µg/L | <0.1 |
| Diclorprop | >99.9% | 150.2 | µg/L | <0.1 |
| 1,2,4-Trichlorobenzene Changes in adrenal glands | >99.8% | 48.4 | µg/L | <0.1 |
| 1,2-Dichlorobenzene | >99.8% | 49.0 | µg/L | <0.1 |
| 1,3-Dichlorobenzene | >99.8% | 49.9 | µg/L | <0.1 |
| 1,4-Dichlorobenzene | >99.8% | 50.1 | µg/L | <0.1 |
| 2,2-Dimethylphenol | >99.8% | 48.1 | µg/L | <0.1 |
| 2,2-Oxybis(1-chloropropane | >99.8% | 49.2 | µg/L | <0.1 |
| 2,4-Dichlorophenol Increase risk of | >99.8% | 48.9 | µg/L | <0.1 |
| 2,4-Dinitrophenol | >99.8% | 50.1 | µg/L | <0.1 |
| 2,4-Dinitrotoluene | >99.8% | 49.2 | µg/L | <0.1 |
| 2,6-Dinitrotoluene | >99.8% | 48.5 | µg/L | <0.1 |
| 2-Chloronaphthalene | >99.8% | 49.4 | µg/L | <0.1 |
| 2-Chlorophenol | >99.8% | 49.0 | µg/L | <0.1 |
| 4-Bormophenyl phenyl | >99.8% | 47.8 | µg/L | <0.1 |
| 4-Chloro-3-methylphenol | >99.8% | 50.6 | µg/L | <0.1 |
| 4-Chlorophenyl phenyl Irritates skin and eyes | >99.8% | 49.8 | µg/L | <0.1 |
| disturbances, tachycardia and | >99.8% | 47.5 | µg/L | <0.1 |
| Acenaphthylene | >99.8% | 50.1 | µg/L | <0.1 |
| stomach and intestines | >99.8% | 49.5 | µg/L | <0.1 |
| Benzo(a) anthracene | >99.8% | 50.3 | µg/L | <0.1 |
| Benzo(a) pyrene | >99.8% | 50.5 | µg/L | <0.1 |
| system | >99.8% | 50.2 | µg/L | <0.1 |
| Benzo(k) anthracene | >99.8% | 50.3 | µg/L | <0.1 |
| Benzyl butyl phthalate Irritates the eyes, nose, | >99.8% | 50.9 | µg/L | <0.1 |
| when ingested | >99.8% | 47.1 | µg/L | <0.1 |
| Bis(2-chloroethyl) ether Irritates the nose and | >99.8% | 51.6 | µg/L | <0.1 |
| Bis(2-ethylhexyl) phthalate | >99.8% | 52.6 | µg/L | <0.1 |
| Chrysene | >99.8% | 50.5 | µg/L | <0.1 |
| Dibenzo(a,h)anthracene | >99.8% | 50.3 | µg/L | <0.1 |
| and/or | >99.8% | 50.1 | µg/L | <0.1 |
| Dimethylphthalate | >99.8% | 49.2 | µg/L | <0.1 |
| Di-n-butylphthalate | >99.8% | 50.3 | µg/L | <0.1 |
| breathing, coma and death | >99.8% | 48.5 | µg/L | <0.1 |
| Di-n-octyl phthalate | >99.8% | 50.1 | µg/L | <0.1 |
| Diphenylamine | >99.8% | 73.2 | µg/L | <0.1 |
| Fluoranthene | >99.8% | 50.4 | µg/L | <0.1 |
| Fluorene | >99.8% | 49.8 | µg/L | <0.1 |
| Hexachlorobutadiene | >99.8% | 49.6 | µg/L | <0.1 |
| Hexachlorocyclopentadiene | >99.8% | 50.9 | µg/L | <0.1 |
| nuerological systems | >99.8% | 48.4 | µg/L | <0.1 |
| Indeno(1,2,3-cd) pyrene | >99.8% | 50.8 | µg/L | <0.1 |
| Isophrone Dizziness, fatigue, and depression | >99.8% | 50.0 | µg/L | <0.1 |
| Naphthalene Hemolytic anemia | >99.8% | 48.3 | µg/L | <0.1 |
| Nitrobenzene | >99.8% | 48.9 | µg/L | <0.1 |
| N-Nitrosodimethylamine | >99.8% | 50.2 | µg/L | <0.1 |
| N-Nitroso-di-n-propylamine | >99.8% | 50.2 | µg/L | <0.1 |
| Pentachlorophenol | >99.8% | 50.3 | µg/L | <0.1 |
| Phenantherene | >99.8% | 49.8 | µg/L | <0.1 |
| Phenol Irritating to the skin, eyes, and mucous | >99.8% | 50.1 | µg/L | <0.1 |
| Pyrene | >99.8% | 49.6 | µg/L | <0.1 |
| 3,5-Dichlorobenzoic | >99.7% | 30.9 | µg/L | <0.1 |
| Acenaphthene | >99.7% | 35.9 | µg/L | <0.1 |
| immune deficiencies | >99.0% | 10.4 | µg/L | <0.1 |
| TCPP | 100.0% | 4380 | µg/L | <2 |
| Carbamazepine | 99.9% | 2926 | µg/L | <2 |
| low | 99.9% | 1797 | µg/L | 2 |
| Metolachlor | 99.9% | 2520 | µg/L | <2 |
| TCEP | 99.9% | 1921 | µg/L | <2 |
| Acetaminophen | 99.4% | 332 | µg/L | 2 |
| Naproxen | 99.2% | 240 | µg/L | <2 |
| Nonylphenol | 99.2% | 2600 | µg/L | 20 |
| Caffeine | 98.9% | 185 | µg/L | 2 |
| system side | 98.7% | 151 | µg/L | <2 |
| Testosterone | 98.7% | 156 | µg/L | 2 |
| Trimethoprim | 98.6% | 143 | µg/L | <2 |
| Bisphenol A | 98.5% | 2014 | µg/L | 31 |
| Linuron | 98.1% | 107 | µg/L | <2 |
| Atenolol | 97.9% | 96 | µg/L | <2 |
| Ibuprofen | 97.6% | 83 | µg/L | <2 |
| Meprobamate | 96.7% | 61 | µg/L | <2 |
| Estradiol | 91.3% | 23 | µg/L | <2 |
| Bromoform | 99.9% | 85.2 | µg/L | 0.1 |
| Chlorodibromomethane | 99.9% | 82.6 | µg/L | 0.1 |
| Total Trihalomethanes | 99.6% | 339.5 | µg/L | 1.2 |
| Chloroform | 99.0% | 86.9 | µg/L | 0.9 |
| Chlorine | 98.9% | 1.8 | mg/L | 0.02 |
| Chloramine | 98.1% | 3.2 | mg/L | 0.06 |
| Chloride | 17.6% | 170 | mg/L | 140 |
| shortness of breath | 16.0% | 25 | mg/L | 21 |
| Sulfate | 4.0% | 603 | mg/L | 579 |
| mottled teeth | 0.0% | 7.8 | mg/L | 7.8 |
Källa: AlkaViva, UltraHome Whole House Water Filtration System Testing Protocol, QFT Labs 2022-06-08. Översättning: Livsvatten. Ladda ner original-PDF.